maraviroc

FDA Drug Profile — SELZENTRY

maraviroc is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including SELZENTRY. Available dosage forms: tablet, film coated, kit.

Drug details

Generic Name
maraviroc
Brand Names
SELZENTRY
Application Number
NDA022128
Sponsor
A-S Medication Solutions
NDC Codes
4
Dosage Forms
TABLET, FILM COATED, KIT
Routes
ORAL
Active Ingredients
MARAVIROC

Indications and Usage

1 INDICATIONS AND USAGE Maraviroc is indicated in combination with other antiretroviral agents for the treatment of only CCR5‑tropic human immunodeficiency virus type 1 (HIV‑1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg. Limitations of Use Maraviroc is not recommended in patients with dual/mixed- or CXCR4-tropic HIV- 1 [see Microbiology (12.4) ] . Maraviroc is a CCR5 co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg. ( 1 ) Limitations of Use: • Not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.